Read a case study on the PRECICE® Intramedullary Limb Lengthening System, now being used at UVA to treat select patients with congenital short femur.
Author: hford (Page 31)
Two clinicians at UVA Children’s Hospital are working to strengthen the link between parents and providers after the patient is discharged from the hospital.
UVA researchers used a smartphone’s accelerometer to assess the forces acting on blood samples during transit in the hospital's pneumatic tube system.
William (Bill) Fulkerson, who has more than 15 years of leadership experience at academic medical centers, will begin as UVA Medical Center's chief operating officer beginning Aug. 1.
UVA researchers have turned to genetics to learn more about the biology of ischemic stroke.
The Center to Advance Palliative Care (CAPC) has designated UVA Health System as a Palliative Care Learning Center (PCLC) for their success in providing comprehensive palliative care in the ambulatory setting.
For the second consecutive year, UVA Medical Center has been honored by Becker’s Hospital Review as one of “100 hospitals and health systems with great women’s health programs.”
UVA Cancer Center has launched a social network that will build a community of informed, proactive individuals who want to leverage the knowledge and resources available to make the best decisions possible regarding their healthcare.
Physicians at UVA were among the first in the country to implant the Medtronic MRI-compatible three-lead Amplia MRI™ and Compia MRI™ ICDs, which provide pacing in both ventricles as well as the right atrium.
UVA is conducting an FDA-approved clinical trial of prostate artery embolization (PAE), a new interventional therapy that has shown potential for relieving benign prostate hypertrophy symptoms without side effects.